CIDNITAB T 20/40 (Cilnidipine (20mg) + Telmisartan (40mg))

Cidnitab T 20/40 Tablet is indicated primarily for the management of hypertension, a condition characterized by elevated blood pressure, which can lead to serious cardiovascular events such as heart attacks. This formulation is a combination of active ingredients classified under antihypertensive medications. It functions by decreasing the workload on the heart and the vascular system, thereby aiding in the regulation of blood pressure levels. Prior to initiating treatment, it is crucial to disclose any existing health issues to your healthcare provider to tailor the therapy appropriately. Adherence to the recommended dosage and administration schedule is essential for optimal therapeutic outcomes. Patients should remain vigilant and report any adverse effects experienced during the course of treatment, as this allows for timely adjustments and ensures patient safety. Effective management of hypertension is vital to enhance overall health and reduce the risk of serious complications. Use this medicine only under medical supervision. Follow the dose and schedule exactly as advised. Do not stop abruptly without guidance. Keep a record of any unusual symptoms and share them with your clinician. Combine therapy with appropriate lifestyle measures and routine monitoring as recommended. Use this medicine only under medical supervision. Follow the dose and schedule exactly as advised. Do not stop abruptly without guidance. Keep a record of any unusual symptoms and share them with your clinician. Combine therapy with appropriate lifestyle measures and routine monitoring as recommended.